CLINICAL_TRIALS
trial_result
· 2014-10-06
Clinical Trial Update: A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009) [Phase 2]
Summary
A Phase 2 clinical trial evaluating Navarixin (MK-7123) for psoriasis has completed and posted results in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-06